Beltran et al. demonstrated that the circulating tumor cells from patients with neuroendocrine prostate cancer exhibited a unique structure, had subdued androgen receptor expression, and lower epithelial markers compared to those from patients with castration-resistant prostate cancer [42]. This evidence concerns the gene AR and prostate cancer.